patient: BRCA2 c.7976G>A het, p.Arg2659Lys and RAD50 c.287T>C het, p.Val96Ala, which are pathogenic and VUS, respectively; the patient has been receiving treatment for Grade 3 triple negative, invasive ductal carcinoma as well, which was diagnosed at the age of 29 years. This evidence concerns the gene BRCA2 and invasive ductal breast carcinoma.